Feedback
  • Article / Essay
  • Editorial: Therapeutic targeting of splicing variants in cancer

Editorial: Therapeutic targeting of splicing variants in cancer

Affiliation
Independent Researcher ,Puebla ,Mexico
Sarvari, Pouya;
Affiliation
International Laboratory EPIGEN ,Consejo de Ciencia y Tecnología del Estado de Puebla (CONCYTEP) ,Instituto de Ciencias ,Benemérita Universidad Autónoma de Puebla (BUAP) ,Puebla ,Mexico
Rubio, Karla;
Affiliation
Human Biology Division ,Fred Hutchinson Cancer Center, Seattle ,WA ,United States
Dobersch, Stephanie;
Affiliation
Yale Cardiovascular Research Center ,Section of Cardiovascular Medicine ,New Haven ,CT ,United States
Ntokou, Aglaia;
Affiliation
Centro de Investigación Biomédica de Oriente ,Instituto Mexicano del Seguro Social ,Puebla ,Mexico
Vallejo-Ruiz, Verónica

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (05.05.2023)
Volume:
14
Date Issued:
05.05.2023
DOI:
10.3389/fphar.2023.1206342
Language:
English
Type of Resource:
Text
Keywords:
alternative splicing; spliceosome; splicing factors; aberrant splicing; pre-mRNA
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Sarvari, Rubio, Dobersch, Ntokou and Vallejo-Ruiz.

Use and reproduction: